Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Affymax, Inc. (OP: AFFY)
Streaming Delayed Price  /  Updated: 8:10 PM EDT, Apr 15, 2014  /  Add to My Watchlist      
(AFFY) Community Analysis from
April 16, 2014
Hammered small cap biotech stocks are jumping today, another sign investors are searching for anything with even a faint pulse to buy. Affymax, Inc. (NASDAQ:AFFY) is trading at $1.10, +0.30 (37.48%)...(read more)
(Stock Blog Hub, 3/23/13)
Affymax, Inc. (AFFY) recently announced that it will reduce its total workforce by approximately 75% (230 employees). The company took this decision after it recalled all lots of Omontys...(read more)
(Benzinga, 11/1/11)
Affymax (NASDAQ: AFFY) is a small-cap biopharmaceutical company that focuses on various hostile diseases. It is trying to break into the mature pharmaceutical space, and it seems that investors...(read more)
Affymax (AFFY) Company Overview

There is no analysis for AFFY yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here